跳至主要内容
临床试验/NCT05982340
NCT05982340已完成不适用

Endogenous Lithium Clearance in Acute Kidney Injury

University Hospital of North Norway1 个研究点 分布在 1 个国家目标入组 20 人开始时间: 2023年8月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
20
试验地点
1
主要终点
Renal lithium clearance

研究概览

简要总结

Critically ill patients are at high risk of developing acute kidney injury (AKI). Lithium is freely filtrated at the glomerulus and almost completely reabsorbed in the proximal tubule, which provides a quantitative estimation of proximal tubule reabsorption. The investigators hypothesized that endogenous lithium reabsorption is impaired in the early stages of critical illness.

Investigators would like to study 10 ICU patients with AKI diagnosed, 10 patients without AKI, and 10 healthy controls.

详细描述

Blood and urine samples will be obtained at 08:00, 14:00 and 20:00 during one day. Renal clearance of creatinine (CCr) and lithium will be calculated.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
是

入选标准

  • •ICU patients diagnosed with AKI, without AKI and healthy controls

排除标准

  • 未提供

结局指标

主要结局

Renal lithium clearance

时间窗: 2 days

Clearance of lithium from the body

次要结局

未报告次要终点

研究者

发起方
University Hospital of North Norway
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验